Stéphanie Henry

2.2k total citations
41 papers, 680 citations indexed

About

Stéphanie Henry is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Stéphanie Henry has authored 41 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 7 papers in Epidemiology. Recurrent topics in Stéphanie Henry's work include Cancer-related Molecular Pathways (6 papers), PARP inhibition in cancer therapy (6 papers) and Lung Cancer Treatments and Mutations (5 papers). Stéphanie Henry is often cited by papers focused on Cancer-related Molecular Pathways (6 papers), PARP inhibition in cancer therapy (6 papers) and Lung Cancer Treatments and Mutations (5 papers). Stéphanie Henry collaborates with scholars based in Belgium, United States and Spain. Stéphanie Henry's co-authors include Sandra Schmitz, Sylvie Zanetta, J. Guigay, Anne-Françoise Dillies, Anne Moxhon, Emmanuelle Bompas, Justin L. Mott, Jean‐Pascal Machiels, Greg A. Gerhardt and Craig van Horne and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Stéphanie Henry

37 papers receiving 671 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stéphanie Henry Belgium 13 295 204 192 165 131 41 680
Kara L. Hamilton‐Nelson United States 15 146 0.5× 269 1.3× 226 1.2× 31 0.2× 25 0.2× 33 649
U. Häuser Germany 12 193 0.7× 152 0.7× 153 0.8× 378 2.3× 22 0.2× 26 826
Dora L.W. Kwong Hong Kong 6 70 0.2× 86 0.4× 54 0.3× 86 0.5× 17 0.1× 9 394
Thomas F. Barrett United States 12 146 0.5× 70 0.3× 150 0.8× 55 0.3× 14 0.1× 26 495
Elvira La Mantia Italy 13 131 0.4× 172 0.8× 211 1.1× 13 0.1× 28 0.2× 29 527
Brittany Voth United States 13 59 0.2× 57 0.3× 107 0.6× 24 0.1× 43 0.3× 29 508
Finn Ø. Winther Norway 14 217 0.7× 191 0.9× 80 0.4× 321 1.9× 22 0.2× 37 721
Kimberly Hoang United States 10 63 0.2× 51 0.3× 159 0.8× 115 0.7× 16 0.1× 14 609
Olga Dratviman‐Storobinsky Israel 15 63 0.2× 28 0.1× 214 1.1× 15 0.1× 26 0.2× 31 509
Dominique Higgins United States 12 99 0.3× 340 1.7× 334 1.7× 6 0.0× 47 0.4× 30 801

Countries citing papers authored by Stéphanie Henry

Since Specialization
Citations

This map shows the geographic impact of Stéphanie Henry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphanie Henry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphanie Henry more than expected).

Fields of papers citing papers by Stéphanie Henry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphanie Henry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphanie Henry. The network helps show where Stéphanie Henry may publish in the future.

Co-authorship network of co-authors of Stéphanie Henry

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphanie Henry. A scholar is included among the top collaborators of Stéphanie Henry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphanie Henry. Stéphanie Henry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Henry, Stéphanie, et al.. (2025). Adenosine A2A receptor modulation affects the development of depressive-like behaviour and dopamine D2 receptor availability in rats exposed to repeated social defeat. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 142. 111540–111540.
2.
3.
Shah, Kavit, Cynthia L. Kenmuir, Shashvat M. Desai, et al.. (2024). Safety and Feasibility of a “Fast‐Track” Monitoring Protocol for Patients Treated With Intravenous Thrombolytic Therapy. SHILAP Revista de lepidopterología. 4(3). e001098–e001098.
4.
Heitz, Florian, Christian Marth, Stéphanie Henry, et al.. (2023). AGO-OVAR 28/ENGOT-ov57. Niraparib alone versus niraparib in combination with bevacizumab in patients with carboplatin-taxane-based chemotherapy in advanced ovarian cancer: a multicenter randomized phase III trial. International Journal of Gynecological Cancer. 33(12). 1966–1969. 11 indexed citations
5.
6.
Jaeghere, Emiel A. De, Sandra Tuyaerts, Ann Belmans, et al.. (2022). 2022-RA-638-ESGO Pembrolizumab with multimodal immunomodulation in chemotherapy-pretreated cervical, endometrial, and uterine cancer: the PRIMMO phase II trial. International Journal of Gynecological Cancer. 32. A187–A188.
7.
Henry, Stéphanie, et al.. (2021). Leptomeningeal Carcinomatosis: A Call for Optimizing Diagnostic Sensitivity by the Hematology Laboratory. Case Reports in Oncology. 14(2). 1248–1253. 3 indexed citations
8.
9.
Jaeghere, Emiel A. De, Sandra Tuyaerts, An M. T. Van Nuffel, et al.. (2021). 159P Pembrolizumab, SBRT, and immunomodulation for recurrent and/or refractory cervical or endometrial carcinoma. Annals of Oncology. 32. S1449–S1450. 1 indexed citations
10.
Goldstein, Lori J., Mauro Mansutti, Christelle Lévy, et al.. (2020). Abstract P3-11-07: A randomized phase II trial of reparixin, a CXCR1 inhibitor, in combination with paclitaxel in the treatment of mTNBC. Cancer Research. 80(4_Supplement). P3–11. 3 indexed citations
11.
Henry, Stéphanie, Didier Lereclus, & Leyla Slamti. (2020). The Alternative Sigma Factor SigB Is Required for the Pathogenicity of Bacillus thuringiensis. Journal of Bacteriology. 202(21). 2 indexed citations
12.
Seront, Emmanuel, Sandra Schmitz, Aline van Maanen, et al.. (2019). Phase 1 Study Evaluating the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib and Cetuximab in Recurrent/Metastatic p16-Negative Squamous Cell Carcinoma of the Head and Neck. Frontiers in Oncology. 9. 155–155. 17 indexed citations
13.
Chang, Anne Lynn S., Shalini Mohan, Julia Chang, et al.. (2016). 156 Increased risk of cutaneous squamous cell carcinoma after vismodegib therapy for basal cell carcinoma. Journal of Investigative Dermatology. 136(5). S28–S28. 2 indexed citations
14.
Seront, Emmanuel, Sandra Schmitz, Sylvie Rottey, et al.. (2016). Phase I study of ribociclib plus cetuximab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Annals of Oncology. 27. vi345–vi345. 3 indexed citations
15.
Guigay, J., Jérôme Fayette, Anne-Françoise Dillies, et al.. (2015). Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study. Annals of Oncology. 26(9). 1941–1947. 100 indexed citations
16.
Schmitz, Sandra, Stéphanie Henry, L. Geoffrois, et al.. (2012). Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02). Annals of Oncology. 23(8). 2153–2161. 62 indexed citations
17.
Machiels, Jean‐Pascal, Stéphanie Henry, Sylvie Zanetta, et al.. (2009). Phase II Study of Sunitinib in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: GORTEC 2006-01. Journal of Clinical Oncology. 28(1). 21–28. 129 indexed citations
18.
Henry, Stéphanie, Lionel D’Hondt, M. André, Xavier Holemans, & Jean Luc Canon. (2004). SACCHAROMYCES CEREVISIAE FUNGEMIA IN A HEAD AND NECK CANCER PATIENT: A CASE REPORT AND REVIEW OF THE LITERATURE. Acta Clinica Belgica. 59(4). 220–222. 24 indexed citations
19.
Sheldon, Julie, Stéphanie Henry, Monique Bodéus, et al.. (2000). Human herpes virus 8 infection in kidney transplant patients in Belgium. Nephrology Dialysis Transplantation. 15(9). 1443–1445. 15 indexed citations
20.
Henry, Stéphanie, Karl H. Pfenninger, Justin L. Mott, & A.-Ch. Granholm. (1999). Anatomical distribution of glycoprotein 93 (gp93) on nerve fibers during rat brain development.. Cell and Tissue Research. 297(1). 67–79. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kara L. Hamilton‐Nelson Breakdown of academic impact, for papers by U. Häuser Breakdown of academic impact, for papers by Dora L.W. Kwong Breakdown of academic impact, for papers by Thomas F. Barrett Breakdown of academic impact, for papers by Elvira La Mantia Breakdown of academic impact, for papers by Brittany Voth Breakdown of academic impact, for papers by Finn Ø. Winther Breakdown of academic impact, for papers by Kimberly Hoang Breakdown of academic impact, for papers by Olga Dratviman‐Storobinsky Breakdown of academic impact, for papers by Dominique Higgins
Rankless by CCL
2026